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Abstract 
This study explored the current medical nutrition therapy (MNT) provided to adult patients under-
going hematopoietic stem cell transplantation (HSCT) and examined the current and desired role of 
registered dietitians (RDs) in providing MNT. A total of 60 RDs (57% response rate) responded to an 
electronic questionnaire. Descriptive statistics and χ2 analyses (SPSS, version 18) were used. Results 
revealed the primary form of diet was oral, and for patients on nutrition support, parenteral nutrition 
(PN) was used more frequently (16%–31%) than enteral nutrition (EN) (5%–9%; P ≤ .05). Nutrition 
support decisions were based on patients’ individualized needs rather than established protocol or 
policies. Mucositis was the most common reason for implementing PN (31%), and intubation or be-
ing in the intensive care unit was the most common reason for implementing EN (28%). The RDs had 
varying degrees of autonomy in order writing and were most often recommending MNT to the phy-
sician or writing the MNT order with a physician cosignature. Many RDs reported desiring higher 
autonomy than what they were currently practicing (P < .05). Those who held a certified specialist in 
oncology (CSO) or certified nutrition support dietitian/clinician (CNCD/C) certification were signif-
icantly more likely to have and desire greater autonomy in order writing than those without specialty 
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credentials (P ≤ .05). No difference was found in current practice or desired autonomy based on the 
years of experience or educational degree. 
 
Keywords: nutrition therapy, stem cell transplantation, parenteral nutrition, enteral nutrition 
 
Patients undergoing hematopoietic stem cell transplantation (HSCT) have increased met-
abolic demands and are at increased nutrition risk.1 Complications that affect appetite and 
oral intake include nausea, vomiting, dysgeusia, diarrhea, mucositis, anorexia, and xero-
stomia.2 Therefore, consuming adequate calories to prevent weight loss is challenging and 
may result in the use of nutrition support.3 
Opinions vary on when to initiate nutrition support for HSCT recipients and whether 
the nutrition support provided should be parenteral nutrition (PN) or enteral nutrition 
(EN).2 Traditionally, the use of PN has been the primary method of nutrition support for 
HSCT recipients. However, past studies4–8 have suggested that PN use may be associated 
with increased incidence of hyperglycemia and infection, delayed engraftment, and in-
creased length of hospitalization without positively affecting clinical outcomes. Conversely, 
EN has been associated with decreased development of acute-grade III/IV graft vs host 
disease (GVHD) and mortality from infection during the first 100 days after transplant.4 
Strong evidence to support standards for when to initiate nutrition support (PN or EN) is 
lacking.9 
Registered dietitians (RDs) work closely with an interdisciplinary team to assist in mak-
ing decisions on PN and EN feedings but experience varying degrees of autonomy in this 
process.1,10 Most currently practicing RDs do not hold order-writing privileges but value 
independent and dependent prescriptive authority.10 
Although published literature exists on advantages and disadvantages of PN and EN 
use in HSCT patients, there have been limited studies on the medical nutrition therapy 
(MNT) actually provided to this population. The purpose of this study was to determine 
the current MNT provided to adult patients undergoing HSCT and examine the current 
and desired role of dietitians in providing MNT to HSCT patients. 
 
Methods 
 
This study used a cross-sectional survey research design. An online questionnaire was pro-
vided through Survey Monkey (Chicago, Illinois). The study was approved by the Medical 
Center’s institutional review board (IRB) prior to data collection. 
 
Sample Selection 
The target population for this study was RDs currently practicing in adult HSCT facilities 
in the United States. The research sample was obtained through contact information from 
the Blood and Marrow Transplant Information Network, listed by state on the website 
(www.bmtinfonet.org). The researcher called all US transplant centers (n = 155) and re-
quested contact information for the RDs employed. Of the 155 contacted, contact infor-
mation from 105 centers was obtained. An email requesting participation was sent to these 
RDs. In addition, RDs were asked to forward a link to a physician questionnaire to an 
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HSCT physician on their team. As only 11 physicians responded, only information from 
RDs will be discussed in this article. 
 
Questionnaire Development 
The questionnaire developed for the RDs had 5 main sections. In the first section, RDs were 
asked to indicate their current role and the role the RD should have in 9 different order-
writing situations. The second section included questions on MNT practices (i.e., use of 
low bacterial content diets, methods used to assess nutrition intake). The third and fourth 
sections on PN and EN asked questions regarding the use of nutrition support on specific 
patient types (autologous or allogeneic), perceived barriers to initiating nutrition support, 
reasons for initiation and discontinuance of nutrition support, and duration of use. The 
final section asked questions regarding agreement on nutrition practices, preferred meth-
ods for providing nutrition to HSCT patients, and the perceived barriers to providing op-
timal nutrition. Depending on various screening questions, the total number of answers 
able to be provided by participants completing the questionnaire was 49, which was esti-
mated to take approximately 30 minutes to complete, based on information from a pilot 
study. This included 13 open-ended and 36 close-ended questions. 
 
Data Collection 
Data collection followed recommendations by Dillman.11 The cover letter and link to the 
electronic questionnaires were emailed to the RD sample in June 2011. The email explained 
the study’s purpose, importance, voluntary nature of participation, and confidentiality of 
responses. A total of 3 follow-up emails were sent to the RDs thanking those who had 
completed the questionnaire for their participation and encouraging those who had not 
completed the questionnaire to do so. Participants were provided a summary of the find-
ings from the research to facilitate benchmarking their practice with other HSCT facilities. 
 
Data Analysis 
Statistical software, Statistical Package for the Social Sciences (version 18.0, 2011, SPSS, Inc., 
an IBM Company, Chicago, Illinois), was used for all data analyses. To decrease bias, par-
ticipants who left more than 50% of questions unanswered were excluded from the study. 
Descriptive statistics were completed for all variables. An independent t test was used to 
determine difference between mean PN and EN duration of use. χ2 analyses were used to 
determine differences between the RD’s current role and his or her perceived ideal role in 
order writing and to explore differences in current and desired autonomy in order-writing 
privileges based on specialty credentials, years of experience, and education level. 
 
Results 
 
A total of 60 RDs (57% response rate) completed the online questionnaire. A majority of 
RD respondents had a bachelor’s degree (59%), 39% had a master’s degree, and 2% had a 
doctorate degree. Most worked exclusively with adult HSCT patients (85%) and had been 
a RD for an average of 12 years. Many held no additional specialty certifications (45%), 
although 30% were certified nutrition support clinicians/dietitians (CNSC/D), and 22% 
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were certified specialists in oncology (CSO). Respondents had worked with HSCT patients 
for an average of 7 years. 
 
Nutrition Practices 
Almost all (88%) RDs responded that they used some type of low bacterial content diet 
(components of diet were not evaluated) that was most often (57%) initiated upon patient 
admission as opposed to a specific absolute neutrophil count (ANC). Approximately three-
quarters (77%) of respondents reported that calorie counts were conducted on HSCT pa-
tients; however, only 11% reported that these were routinely done on HSCT patients and 
most (72%) were requested by the RD. The nurse or nurse assistant most often recorded 
the calorie counts (74%) while the RD analyzed the data (85%). The most commonly men-
tioned barrier to implementing calorie counts was labor and staffing (52%). When asked if 
RDs participate in daily rounds with other healthcare professionals, more than half (57%) 
responded that they did not, and the most common reason for not participating was a lack 
of time (47%). Finally, the majority of RDs (63%) did not meet with patients in an outpatient 
setting prior to transplantation. 
 
PN Use 
Almost all respondents (98%) had used PN at their facility, and the decision to initiate PN 
was almost exclusively individualized to the patient (97%) rather than under an estab-
lished policy or protocol. Table 1 indicates the MNT practices of PN for HSCT patients 
with regard to percent and duration of nutrition support use by donor type, which was 
estimated by the RD. PN was used in approximately 16% of autologous patients, 29% of 
allogeneic-related donor patients, and 31% of allogeneic-unrelated donor patients. The 
RDs (61%) reported that the percentage of energy provided in PN was primarily depend-
ent on oral intake, and approximately two-thirds (68%) discontinued PN when oral intake 
(or enteral tube feeding) was > 50% of needs. The top 3 components of policies, protocols, 
and/or individualized approaches for determining when to implement PN for HSCT pa-
tients included mucositis (31%), gastrointestinal toxicities such as nausea and vomiting 
(19%), and GVHD (17%). 
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Table 1. Medical Nutrition Therapy (MNT) Practices of Parenteral Nutrition (PN) and Enteral Nutrition (EN) 
for Hematopoietic Stem Cell Transplant (HSCT) Patients 
Characteristics PN EN 
Percent of autologous patients on nutrition support   
     Meana 16.5 5.0 
     Range 0.0–100.0 0.0–15.0 
Percent of allogeneic patients on nutrition support   
     Related donor   
          Meana 29.0 7.3 
          Range 0.0–90.0 0.0–30.0 
     Unrelated donor   
          Meana 30.8 9.1 
          Range 0.0–95.0 0.0–50.0 
Days on nutrition support for autologous patients   
     Mean 10.0 18.0 
     Range 0.0–56.0 0.0–112.0 
Days on nutrition support for allogeneic patients   
     Related donor   
          Mean 13.5 14.3 
          Range 0.0–30.0 0.0–30.0 
     Unrelated donor   
          Mean 16.1 17.5 
          Range 0.0–35.0 0.0–42.0 
If a range was provided, the highest number in the range was used for calculation. Information provided is 
based on registered dietitian estimates of use. 
a. P ≤ .05, analysis of variance comparison of PN and EN use 
 
EN Use 
More than half of RDs used EN for HSCT patients (69%), and all (100%) stated that the 
decision to initiate EN was individualized to the patient rather than under policies or pro-
tocols. The majority of RDs did not continue EN if their patient had intractable diarrhea 
(75%), vomiting (93%), or nausea (60%). The percent of energy provided from EN was 
mostly dependent on oral intake (85%), and similar to PN, approximately two-thirds (68%) 
discontinued EN when oral intake was > 50% of needs. The top 3 components of the poli-
cies, protocols, and/or individualized approaches for determining when to implement EN 
for HSCT patients included if the patient was intubated or in the intensive care unit (28%), 
if oral intake was inadequate (23%), and if the physician had requested EN to be initiated 
(10%). 
The RD’s preferred methods of nutrition for HSCT autologous patients varied greatly 
and were fairly evenly distributed with oral intake only, no nutrition support (29%); oral 
intake with EN as needed (29%); and oral intake with PN as needed (27%; Table 2). 
  
HA B S C H M I D T  E T  A L. ,  N U T R I T I O N  I N  CL I N I C A L  PR A C T I C E  27  (2012)  
6 
Table 2. Registered Dietitian (RD) and Physician Preferred 
Method of Nutrition for Hematopoietic Stem Cell Transplant 
(HSCT) Patients 
Characteristics No. (%) 
Preferred nutrition for autologous patients  
   Oral intake only, no nutrition support 16 (28.6) 
   Encourage oral intake, EN as needed 16 (28.6) 
   Encourage oral intake, PN as needed 15 (26.7) 
   Encourage oral intake, combination EN and PN 9 (16.1) 
Preferred nutrition for allogeneic patients  
   Oral intake only, no nutrition support 6 (11.3) 
   Encourage oral intake, EN as needed 15 (28.3) 
   Encourage oral intake, PN as needed 22 (41.5) 
   Encourage oral intake, combination EN and PN 10 (18.9) 
 
Role of the RD in Order Writing 
As indicated in Table 3, more than half of RDs write and modify under protocol with no 
physician cosignature for high-calorie and high-protein snacks (57%) and oral nutrition 
supplement drinks (53%). With regard to oral diet changes, EN formula, EN rate and ad-
ministration, macronutrients in PN, micronutrients in PN, and electrolytes in PN, the most 
common responses were that RDs are recommending to the physician (while the physician 
writes the order) or writing the order with a physician cosignature. Those who held a CSO 
or CNSD/C certification were significantly (P ≤ .05) more likely to have greater autonomy 
in order writing than those without specialty credentials with regard to EN formula, EN 
rate and administration, micronutrients in PN, and electrolytes in PN. There were no dif-
ferences in the RD’s current role based on education (bachelor’s vs. graduate) and years of 
experience (< 5 years vs. ≥ 6 years and < 10 years vs. ≥ 11 years). 
RDs were asked to also rate what role they believed the RD should have in the order-
writing process for the same 9 practice components listed in Table 3. The most common 
response for high-protein and high-calorie snacks (83%), oral nutrition supplement drinks 
(83%), and oral diet changes (72%) was that RDs should write and modify under protocol 
without a physician cosignature. However, more than half the RDs did not believe they 
should write or modify under protocol without a physician cosignature for the remaining 
practice components. A χ2 analysis was used to determine differences between the RD’s 
current and ideal role, shown in Table 3. Overall, with regard to high-protein and high-
calorie snacks, oral nutrition supplement drinks, EN rate and administration, macronutri-
ents in PN, micronutrients in PN, and electrolytes in PN, RDs reported desiring higher 
autonomy in those order-writing components than what they were currently doing (P < .05). 
A χ2 analysis was performed to determine if there was a difference in desired autonomy 
based on credentials held (CSO or CNSD/C certification), education, and years of experi-
ence. RDs who held credentials desired higher autonomy with regard to the decision for 
oral diet changes and EN formula selection (P ≤ .05). There were no significant differences 
in desired autonomy based on education and years of experience. 
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Table 3. Comparison of Registered Dietitian (RD) Currenta and Ideal Roleb with Hematopoietic 
Stem Cell Transplant (HSCT) Patients 
Practice Components 
RD Has No 
Role in Order 
Writing/ 
Recommending, 
No. (%) 
RD 
Recommends/ 
Physician 
Writes Order, 
No. (%) 
RD Writes/ 
Modifies with 
Physician 
Cosignature, 
No. (%) 
RD Writes/ 
Modifies 
under Protocol/ 
No Physician 
Cosignature, 
No. (%) 
High calorie/protein snacks*     
   RD current practice response 1 (1.7) 11 (18.3) 14 (23.3) 34 (56.7) 
   RD ideal practice response 1 (1.7) 0 9 (15.0) 50 (83.3) 
Oral nutrition supplement drinks*     
   RD current practice response 1 (1.7) 10 (16.7) 17 (28.3) 32 (53.3) 
   RD ideal practice response 1 (1.7) 0 9 (15.0) 50 (83.3) 
Oral diet changes     
   RD current practice response 1 (1.7) 26 (43.3) 24 (40.0) 9 (15.0) 
   RD ideal practice response 1 (1.7) 1 (1.7) 15 (25.0) 43 (71.6) 
Enteral nutrition (EN) formula     
   RD current practice response 1 (1.7) 26 (43.4) 28 (46.7) 5 (8.3) 
   RD ideal practice response 1 (1.7) 5 (8.3) 28 (46.7) 26 (43.3) 
EN rate/administration*     
   RD current practice response 1 (1.7) 26 (43.3) 28 (46.7) 5 (8.3) 
   RD ideal practice response 1 (1.7) 6 (10.1) 26 (44.1) 36 (44.1) 
Macronutrients in PN*     
   RD current practice response 7 (11.7) 26 (43.3) 22 (36.7) 5 (8.3) 
   RD ideal practice response 3 (5.0) 10 (16.7) 26 (43.3) 21 (35.0) 
Micronutrients in PN*     
   RD current practice response 15 (25.0) 21 (35.0) 21 (35.0) 3 (5.0) 
   RD ideal practice response 4 (6.7) 14 (23.3) 26 (43.3) 16 (26.7) 
Electrolytes in PN*     
   RD current practice response 16 (26.7) 20 (33.3) 21 (35.0) 3 (5.0) 
   RD ideal practice response 4 (6.6) 16 (26.7) 24 (40.0) 16 (26.7) 
Medications to manage nutrition- 
      related side effects 
    
   RD current practice response 14 (23.3) 42 (70.0) 4 (6.7) 0 
   RD ideal practice response 3 (5.0) 31 (51.7) 22 (36.7) 4 (6.6) 
a. RD responses to question on the RD’s current role. 
b. RD response to question on the RD’s ideal role. 
*P ≤ .05, χ2 analysis differences between RD current and ideal role. 
 
RD Beliefs about Barriers to Nutrition 
The RDs were asked to list barriers to optimal nutrition for HSCT patients. The most com-
mon RD responses included gastrointestinal (GI) toxicities (38%), physician and medical 
staff agreement with care (30%), mucositis (13%), and having a lack of research data and 
protocols for practice (8%). 
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Discussion 
 
Respondents in this study reported between 16% and 31% of autologous and allogeneic 
patients were placed on PN. In a study published in 1998, 32% of autologous patients and 
92% of allogeneic patients were placed on PN,12 and 53% of autologous patients and 65% 
of allogeneic patients were placed on PN from a study published in 2006.13 Results from 
the current study suggest a possible decrease in PN use for HSCT patients over the past 
several years. Potential reasons for the decreased utilization of PN could be attributed to 
new chemotherapy regimens, supportive medications to control for side effects of treat-
ment, or recent studies suggesting the negative consequences of PN use.2,6 
RDs in the current study reported using PN most commonly if a patient had mucositis, 
GI toxicities, and GVHD. According to the American Society for Parenteral and Enteral 
Nutrition (ASPEN) practice guidelines,14 PN should be discontinued when toxicities have 
resolved and stem cells have engrafted. Results from this study suggest that current prac-
tices are relying more on the patient’s ability to consume an oral diet as opposed to whether 
or not engraftment occurred. 
More studies have explored PN practices with adult HSCT patients than have explored 
EN use. In the current study, 98% of respondents reported they might use PN at their fa-
cility if nutrition support was warranted, whereas only 69% used EN if nutrition support 
was indicated for their adult HSCT patients. The use of PN and EN occurred in less than 
one-third of patients, regardless of the type of transplant, suggesting that the use of an oral 
diet was the most common route of nutrition provided to this patient population. PN was 
used significantly more as the nutrition support modality than EN (P ≤ .05) (Table 1). A 
lack of literature exists on the benefits of EN for HSCT patients, which could be contrib-
uting to the greater use of PN, despite understood complications associated with this form 
of nutrition support in this population. Benefits of EN use over PN have been observed 
and include decreased incidence of GVHD and less mortality from infection within the 
first 100 days after transplantation.4 The Academy of Nutrition and Dietetics Evidence 
Analysis Library guideline for HSCT patients states that PN use should occur only in select 
patients due to its increased risk of treatment complications, increased cost, and a signifi-
cant lack of improvements in treatment outcomes.15 
Consistent with findings from Weil et al,10 RDs in this sample also experienced varying 
degrees of autonomy in order-writing privileges, and many RDs desired higher autonomy 
than what they were currently practicing. However, Weil et al.10 evaluated RDs in multiple 
practice areas with general patients, whereas the current study assessed specific nutrition 
order-writing tasks to determine more in-depth autonomy with regard to HSCT patients. 
Determining RDs’ current and ideal practice with HSCT patients could provide insight 
into areas for the development of RD autonomy. Peterson et al.16 studied the influence of 
the RD on order-writing privileges on PN use in a retrospective cohort at a tertiary care 
urban medical center to compare the use of PN on adult outcomes before and after RDs 
were granted order-writing privileges under protocol. After the RDs were granted order-
writing privileges under protocol, overall PN use significantly decreased, including inap-
propriate PN use, despite an increase in hospital admission. The authors from this study 
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concluded that RDs with order-writing privileges have the potential to decrease inappro-
priate PN use and costs in hospital settings, and future studies should focus on the influ-
ence of the RD in advanced practice roles, specifically in nutrition support delivery. 
Therefore, RDs with higher autonomy in order writing could assist in decreasing inappro-
priate PN use and negative outcomes for adult HSCT patients. 
 
Limitations 
Several limitations should be considered when deriving conclusions from this study. A 
moderate response rate for RDs limits the generalizability of results. The response rate 
could be attributed to the length of the questionnaire, potential spam filters in emails, or a 
personal unwillingness to participate through email. Another limitation was allowing 
open-ended responses to some questions in the questionnaire, making categorization dif-
ficult. When the RDs were asked to provide the duration of nutrition support use within 
the past year, they were asked to estimate the duration and not collect actual data, to re-
duce the likelihood of participants discontinuing the survey due to time-consuming re-
sponses, which might have affected accuracy of the data. No question was asked if the RDs 
were currently working with other patient populations, which could provide insight into 
issues related to staffing. Also, no question to identify facility type was asked, which could 
determine regional discrepancies in both care and autonomy; facility questions were not 
asked to increase the response rate, as it was possible that participants might be less likely 
to complete the survey if their answers were associated with their facility. 
 
Conclusions 
 
Results from this study suggest that the use of an oral diet is the primary form of nutrition 
provided to HSCT patients; PN and EN are used when nutrition support is needed for all 
donor types, with PN being used significantly more than EN. However, PN use appears 
to be somewhat less compared with the frequency reported in previous studies. RDs are 
actively involved in the MNT provided to adult HSCT patients; however, they experience 
varying degrees of autonomy and believe the role of the RD should be to recommend 
(while the physician writes the order) or to write and modify with a physician cosignature 
for the majority of practice components. 
In developing future questionnaires, questions regarding facility type should be asked 
to determine differences in nutrition practices and areas of autonomy based on facility 
type, size, and geographic location. In addition, future questionnaires could include inter-
disciplinary members, such as pharmacists and nurse practitioners, to determine similari-
ties and differences in responses among disciplines. Finally, asking questions on the 
various conditioning regimens HSCT patients receive could be used to determine how GI 
toxicities and side effects of the regimens are associated with the increased utilization of 
nutrition support. 
In future studies exploring MNT in HSCT patients, several areas of focus should be con-
sidered, such as exploring the rationale behind PN and EN use for adult patients undergoing 
HSCT since current practices have been proven somewhat inconsistent with evidence-
based practice guidelines. Developing practice guidelines related to nutrition support should 
be developed to improve the level of evidence regarding optimal nutrition for adult HSCT 
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patients. There is also a need to encourage continued professional development of RDs 
working at HSCT facilities to prepare RDs to assume more responsibility for the MNT of 
HSCT patients. 
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